ABSTRACT
Increased awareness regarding the myriad management options for SUI has produced heightened interest in determining standards for outcomes measures, including the reporting of surgical complications ( 11-13 ). Striking proliferation in the surgical options available for SUI treatment has amplified the need of the clinician to obtain an accurate assessment of the impact of any individual intervention. Recent attention to the potential complications of mesh implantation from the FDA has certainly heightened awareness in the urologic community to reporting of complications (https://www.fda.gov/cdrh/safety/102008-surgicalmesh.html). For the clinician to adequately assess results of a specific SUI therapy and counsel patients regarding their options, outcomes must be measured and quantified in a standard and consistent manner to permit purposeful conclusions. In accordance with the current practice patterns of the majority
of urologists, this chapter will focus on the complications of the most common surgical modalities utilized for SUI, namely, pubovaginal and midurethral sling procedures. In analysis of the complications for these procedures it must be noted that the standard of care for quality of life surgical interventions must in many ways exceed commonly ascribed expectations and complication rates held for other life-threatening conditions.
